Fund Holdings — Samsara BioCapital, LLC

Total Portfolio Value:
$642.80M
Total Bought:
$242.54M
Total Sold:
$24.56M
Net Transaction:
+$217.98M
Notable People:
Michael Philip Dybbs
Securities
▲▼
SharesValue
Q3 2023
▲▼
Q4 2023
▲▼
Change
▲▼
Q3 2023
▲▼
Q4 2023
▲▼
Weight (%)
▲▼
Change
▲▼
Scholar Rock Holding Corporation(SRRK)4,598,8286,788,609+2,189,781$32.65M$127.63M19.85%+$94.97M
Rayzebio Inc1,845,9481,845,9480$40.98M$114.76M17.85%+$73.78M
Cargo Therapeutics Inc04,121,689+4,121,689$0$95.42M14.84%+$95.42M
Mineralys Therapeutics, Inc.(MLYS)4,519,3614,519,3610$42.98M$38.87M6.05%-$4.11M
Arcellx Inc
COMMON STOCK
613,921460,441-153,480$22.03M$25.55M3.98%+$3.53M
Neurogene Inc.(NGNE)01,267,790+1,267,790$0$24.57M3.82%+$24.57M
Graphite Bio Inc8,459,3148,459,3140$20.98M$22.16M3.45%+$1.18M
Nkarta, Inc.(NKTX)2,868,0352,868,0350$3.99M$18.93M2.94%+$14.94M
Acelyrin Inc2,381,5792,523,022+141,443$24.22M$18.82M2.93%-$5.40M
Zymeworks Inc.(ZYME)1,458,8751,458,8750$9.25M$15.16M2.36%+$5.91M
Lyra Therapeutics Inc2,780,2612,780,2610$10.87M$14.57M2.27%+$3.70M
Syros Pharmaceuticals Inc881,4501,786,427+904,977$3.48M$13.92M2.16%+$10.43M
Avadel Pharmaceuticals PlcADR967,527967,5270$9.97M$13.66M2.13%+$3.70M
Hillevax Inc799,274799,2740$10.75M$12.83M2.00%+$2.08M
ABIVAX Société AnonymeADS(ABVX)0850,000+850,000$0$9.10M1.41%+$9.10M
Rhythm Pharmaceuticals, Inc.(RYTM)345,293172,647-172,646$7.92M$7.94M1.23%+$20.7K
Sutro Biopharma, Inc.(STRO)1,675,5791,675,5790$5.81M$7.19M1.12%+$1.37M
Verona Pharma PlcADS347,500347,5000$5.66M$6.91M1.07%+$1.24M
Io Biotech Inc3,640,0153,640,0150$5.13M$6.84M1.06%+$1.71M
Inozyme Pharma Inc1,562,5001,562,5000$6.56M$6.66M1.04%+$93.8K
Tango Therapeutics, Inc.(TNGX)630,000630,0000$7.09M$6.24M0.97%-$856.8K
Gossamer Bio, Inc.(GOSS)6,130,2686,130,2680$5.11M$5.59M0.87%+$488.6K
Immatics N.V.SHS(IMTX)396,000396,0000$4.59M$4.17M0.65%-$415.8K
Prime Medicine, Inc.(PRME)470,304470,3040$4.49M$4.17M0.65%-$319.8K
Janux Therapeutics, Inc.(JANX)360,414360,4140$3.63M$3.87M0.60%+$234.3K
PepGen Inc.(PEPG)651,050436,813-214,237$3.31M$2.97M0.46%-$337.0K
Day One Biopharmaceuticals I
COM
196,425196,4250$2.41M$2.87M0.45%+$457.7K
Cypherpunk Technologies Inc.(CYPH)602,203669,303+67,100$831.0K$2.77M0.43%+$1.94M
Rain Oncology Inc2,034,5522,034,5520$1.75M$2.44M0.38%+$688.1K
Terns Pharmaceuticals Inc202,348202,3480$1.02M$1.31M0.20%+$295.4K
Igm Biosciences Inc154,664154,6640$1.29M$1.29M0.20%-$6.2K
Bolt Biotherapeutics Inc1,049,1531,049,1530$1.09M$1.18M0.18%+$83.9K
Aclaris Therapeutics, Inc.(ACRS)696,171696,1710$4.77M$731.0K0.11%-$4.04M
vTv Therapeutics Inc.CL A(VTVT)040,888+40,888$0$470.2K0.07%+$470.2K
Allakos Inc172,089172,0890$390.6K$469.8K0.07%+$79.2K
Viracta Therapeutics Inc689,709689,7090$717.3K$393.1K0.06%-$324.2K
Science 37 Holdings Inc045,000+45,000$0$240.3K0.04%+$240.3K
Kronos Bio Inc78,13178,1310$101.6K$97.7K0.02%-$3.9K
Allovir Inc82,33682,3360$177.0K$56.0K0.01%-$121.0K
Nuvation Bio Inc.W EXP 07 07 202(NUVB)133,333133,3330$13.3K$8.0K0.00%-$5.3K
Surrozen, Inc.W EXP 08 01 203(SRZN)99,99999,9990$4.1K$1.9K0.00%-$2.2K
EYEPOINT PHARMACEUTICALS INCCOM NEW(EYPT)432,0000-432,000$3.45M$0—-$3.45M
IMMUNOCORE HLDGS PLCADS(IMCR)80,9630-80,963$4.20M$0—-$4.20M
INTERCEPT PHARMACEUTICALS INCOM640,6880-640,688$11.88M$0—-$11.88M
SCIENCE 37 HOLDINGS INCCOM900,0000-900,000$360.0K$0—-$360.0K
VTV THERAPEUTICS INCCL A1,635,5090-1,635,509$781.8K$0—-$781.8K
Page 1 of 1
Samsara BioCapital, LLC — 13F Holdings — Q4 2023 | TickerTrail